Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$872M |
| 2 |
Microsoft
MSFT
|
$324M |
| 3 |
Intuit
INTU
|
$313M |
| 4 |
PTC
PTC
|
$289M |
| 5 |
Amazon
AMZN
|
$286M |
Top Sells
| 1 |
Linde
LIN
|
$575M |
| 2 |
Booking.com
BKNG
|
$570M |
| 3 |
Meta Platforms (Facebook)
META
|
$538M |
| 4 |
NVIDIA
NVDA
|
$455M |
| 5 |
Salesforce
CRM
|
$401M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
89bio
ETNB
$1.36B
| $165M | 0.09% |
20,462,905
+3,948,849
| +24% | +$31.9M |
|
202
Magnolia Oil & Gas
MGY
$4.49B
| $162M | 0.09% |
6,450,789
+53,914
| +0.8% | +$1.36M |
|
203
Apollo Global Management
APO
$74.9B
| $161M | 0.09% |
1,179,047
+10,434
| +0.9% | +$1.43M |
|
204
AstraZeneca
AZN
$254B
| $160M | 0.09% |
2,167,241
+122,982
| +6% | +$9.08M |
|
205
PTC Therapeutics
PTCT
$4.34B
| $158M | 0.09% |
2,916,729
+590,814
| +25% | +$32M |
|
206
Walker & Dunlop
WD
$2.78B
| $156M | 0.09% |
1,860,778
+15,678
| +0.8% | +$1.32M |
|
207
Illumina
ILMN
$15.3B
| $154M | 0.08% |
1,924,181
-228,910
| -11% | -$18.3M |
|
208
RTX Corp
RTX
$211B
| $153M | 0.08% |
1,159,640
-6,824
| -0.6% | -$899K |
|
209
Euronet Worldwide
EEFT
$3.71B
| $152M | 0.08% |
1,414,169
+27,787
| +2% | +$2.98M |
|
210
Cimpress
CMPR
$1.5B
| $149M | 0.08% |
3,295,254
+253,893
| +8% | +$11.5M |
|
211
Travere Therapeutics
TVTX
$1.7B
| $148M | 0.08% |
7,528,622
+3,469,990
| +85% | +$68.3M |
|
212
Trip.com Group
TCOM
$46.6B
| $148M | 0.08% |
2,357,083
-55,678
| -2% | -$3.49M |
|
213
Shift4
FOUR
$6.05B
| $146M | 0.08% |
1,731,359
+275,357
| +19% | +$23.3M |
|
214
Vanguard Total International Stock ETF
VXUS
$101B
| $146M | 0.08% |
2,330,013
| – | – |
|
215
Penumbra
PEN
$10.5B
| $145M | 0.08% |
541,317
-55,760
| -9% | -$14.9M |
|
216
Applied Materials
AMAT
$123B
| $144M | 0.08% |
992,358
-2,675,965
| -73% | -$388M |
|
217
Zai Lab
ZLAB
$3.51B
| $142M | 0.08% |
3,813,433
-2,754,459
| -42% | -$103M |
|
218
CVS Health
CVS
$93.2B
| $141M | 0.08% |
2,100,326
+1,335,140
| +174% | +$89.6M |
|
219
Ares Management
ARES
$38.4B
| $140M | 0.08% |
962,773
+117,466
| +14% | +$17M |
|
220
Dollar Tree
DLTR
$21.2B
| $136M | 0.07% |
1,875,523
+22,091
| +1% | +$1.61M |
|
221
Vanguard S&P 500 ETF
VOO
$721B
| $136M | 0.07% |
265,608
-509,538
| -66% | -$260M |
|
222
Janus Henderson Short Duration Income ETF
VNLA
$2.75B
| $136M | 0.07% |
2,756,548
+2,654,439
| +2,600% | +$131M |
|
223
Fiserv
FI
$74.2B
| $135M | 0.07% |
625,963
+146,487
| +31% | +$31.6M |
|
224
Ziff Davis
ZD
$1.56B
| $135M | 0.07% |
3,541,970
+54,475
| +2% | +$2.08M |
|
225
Zurn Elkay Water Solutions
ZWS
$7.49B
| $135M | 0.07% |
4,083,974
+77,378
| +2% | +$2.55M |
|